Clinical Trial Update: Sunitinib in Certain Subtypes of Soft Tissue Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial of sunitinib in certain subtypes of soft tissue sarcoma was terminated; results posted in 2019. No further details provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Columbia University | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: TERMINATED | Results posted: 2019-11-04